Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®)A Review of its Use as a Single-Dose Booster Immunization in Individuals Aged 10–64 Years in the US

被引：0

作者：

Greg L. Plosker

机构：

[1] Wolters Kluwer Health ¦ Adis,

[2] Wolters Kluwer Health,undefined

来源：

BioDrugs | 2009年 / 23卷

关键词：

Pertussis; Diphtheria; Diphtheria Toxoid; Seroprotection Rate; Pertussis Antigen;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：253 / 267

页数：14

共 37 条

[31] Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age
Dagan, R
Igbaria, K
Piglansky, L
Van Brusteghem, F
Melot, V
Kaufhold, A
VACCINE, 1999, 17 (20-21) : 2620 - 2627
[32] Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
Asatryan, Asmik
Meyer, Nadia
Scherbakov, Michael
Romanenko, Victor
Osipova, Irina
Galustyan, Anna
Shamsheva, Olga
Latysheva, Tatiana
Myasnikova, Tatyana
Baudson, Nathalie
Dodet, Monique
Xavier, Stebin
Harrington, Lauriane
Kuznetsova, Anastasia
Campora, Laura
Van den Steen, Peter
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 723 - 730
[33] Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)
Brandon, Donald
Kimmel, Murray
Kuriyakose, Sherine O.
Kostanyan, Lusine
Mesaros, Narcisa
VACCINE, 2020, 38 (12) : 2746 - 2747
[34] Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study
Sancovski, Mauro
Mesaros, Narcisa
Feng, Yang
Angeles Ceregido, M.
Luyts, Dominique
De Barros, Eliana
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (12) : 2873 - 2881
[35] Immunogenicity, Safety, and Antibody Persistence at 3, 5, and 10 Years Postvaccination in Adolescents Randomized to Booster Immunization with a Combined Tetanus, Diphtheria, 5-Component Acellular Pertussis, and Inactivated Poliomyelitis Vaccine Administered with a Hepatitis B Virus Vaccine Concurrently or 1 Month Apart
Embree, Joanne
Law, Barbara
Voloshen, Tim
Tomovici, Antigona
CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (03) : 282 - 290
[36] Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children
Gatchalian, Salvacion R.
Ramakrishnan, Gunasekaran
Bock, Hans L.
Lefevre, Inge
Jacquet, Jeanne M.
HUMAN VACCINES, 2010, 6 (08): : 664 - 672
[37] Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older-Advisory Committee on Immunization Practices (ACIP), 2012 (Reprinted from MMWR, vol 61, pg 468-470, 2012)
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (10): : 968 - 970

← 1 2 3 4 →